Tom Révész

1.5k total citations
33 papers, 997 citations indexed

About

Tom Révész is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Tom Révész has authored 33 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 11 papers in Public Health, Environmental and Occupational Health and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Tom Révész's work include Acute Lymphoblastic Leukemia research (10 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Tom Révész is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Childhood Cancer Survivors' Quality of Life (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Tom Révész collaborates with scholars based in Netherlands, Australia and Germany. Tom Révész's co-authors include Marc Bierings, R. Maarten Egeler, Arjan C. Lankester, Jacques J. M. van Dongen, Janet Poole, Edwin F. E. de Haas, Barbara H. Barendregt, Menno C. van Zelm, Mirjam van der Burg and Marion Schneider and has published in prestigious journals such as The Journal of Immunology, The American Journal of Human Genetics and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Tom Révész

33 papers receiving 969 citations

Peers

Countries citing papers authored by Tom Révész

Since Specialization

Citations

This map shows the geographic impact of Tom Révész's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Révész with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Révész more than expected).

Fields of papers citing papers by Tom Révész

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Révész. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Révész. The network helps show where Tom Révész may publish in the future.

Co-authorship network of co-authors of Tom Révész

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Révész. A scholar is included among the top collaborators of Tom Révész based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Révész. Tom Révész is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aboriginal children with cancer: The patient and healthcare worker perspective 2023 ·Pediatric Blood & Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), Megan E. O’Connell, (unknown), Tom Révész	2
2	Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab 2021 ·Pediatric Blood & Cancer ·Rosemary Sutton, Luciano Dalla Pozza, Seong Lin Khaw, Chris Fraser, Tom Révész, (unknown), Richard Mitchell, Toby N. Trahair, Caroline M. Bateman, Nicola C. Venn, Tamara Law, (unknown), Susan L. Heatley, Barbara J. McClure, Claus Meyer, Rolf Marschalek, Michelle J. Henderson, (unknown), Deborah L. White, Rishi S. Kotecha	17
3	Composite Index for Risk Prediction in Relapsed Childhood Acute Lymphoblastic Leukaemia 2015 ·Haematologica ·Anthony V. Moorman, Julie Irving, Amir Enshaei, Catriona Parker, Rosemary Sutton, Roland P. Kuiper, (unknown), Lynne Minto, Nicola C. Venn, Tamara Law, Jie Yu, Claire Schwab, (unknown), Edwin Sonneveld, Monique L. den Boer, (unknown), Christine J. Harrison, Peter M. Hoogerbrugge, Tom Révész, Vaskar Saha	3
4	Impact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity* 2011 ·British Journal of Haematology ·Cornelis M. van Tilburg, Elisabeth A. M. Sanders, Elisabeth E. Nibbelke, Rob Pieters, Tom Révész, Paul Westers, Tom F.W. Wolfs, Marc Bierings	10
5	Chemokine/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: Differential roles for CCR2, CCR5, CXCR4 and CXCR7 2010 ·Pediatric Blood & Cancer ·(unknown), Annemieke Willemze, Tom Révész, (unknown), Cornelis P. Tensen, Manja Hoogeboom, Maarten H. Vermeer, (unknown), C. Michel Zwaan, Gertjan J.L. Kaspers, Colin Story, Astrid G. S. van Halteren, Jaak M. Vossen, R. Maarten Egeler, Maarten J. D. van Tol, Nicola Annels	43
6	Increased T regulatory cells and decreased Th1 pro-inflammatory cytokines correlate with culture-positive infection in febrile neutropenia childhood oncology patients 2010 ·Cytokine ·Greg Hodge, Julius Xavier Scott, Michael Osborn, Luen Bik To, Heddy Zola, Sandra Hodge, Tom Révész	6
7	Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11 (vol 39, pg 1434, 2007) 2008 ·UCL Discovery (University College London) ·Henry Houlden, J J Johnson, Christopher Gardner‐Thorpe, Tammaryn Lashley, Dena Hernández, Paul Worth, A. B. Singleton, (unknown), JL Holton, Tom Révész, (unknown), Paola Giunti, Nicholas Wood	18
8	Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: Is the risk of lethal infections too high? 2007 ·European Journal of Cancer ·(unknown), Eveline S.J.M. de Bont, H. Marike Boezen, Tom Révész, Jos P.M. Bökkerink, Auke Beishuizen, Ilse J.M. Nijhuis, (unknown), A. Veerman, Willem A. Kamps	25
9	Effect of factor VIII concentrate on leucocyte cytokine receptor expression in vitro: relevance to inhibitor formation and tolerance induction 2006 ·Haemophilia ·Greg Hodge, Ben Saxon, Tom Révész	13
10	Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia 2005 ·Leukemia ·Ayami Yoshimi, Peter Bader, Susanne Matthes‐Martin, Jan Starý, Petr Sedláček, Ulrich Duffner, Thomas Klingebiel, Dagmar Dilloo, Wolfgang Holter, F Zintl, Bernhard Kremens, K-W Sykora, Christian Urban, Henrik Hasle, Elisabeth T Korthof, Tom Révész, Alexandra Fischer, Peter Nöllke, Franco Locatelli, Charlotte M. Niemeyer, (unknown)	58
11	How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! 2005 ·Bone Marrow Transplantation ·Martin B.A. Heemskerk, Suzanna M. van Walraven, J.J. Cornelissen, R M Y Barge, Robbert G. M. Bredius, R. Maarten Egeler, (unknown), Tom Révész, K. Sintnicolaas, N. M. Wulffraat, Albertine E. Donker, Peter M. Hoogerbrugge, J. J. van Rood, Frans H.J. Claas, Machteld Oudshoorn	74
12	Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood: results of a prospective study 2004 ·British Journal of Haematology ·Marrie C.A. Bruin, Marc Bierings, (unknown), Tom Révész, L. Bode, (unknown), Taco W. Kuijpers, R. Y. J. Tamminga, Masja de Haas	52
13	Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: risks and benefits 2003 ·Bone Marrow Transplantation ·M. Loes van Kempen-Harteveld, (unknown), C. W. EMMENS, Evert M. Noordijk, Ingeborg van der Tweel, Tom Révész, H. Struikmans, Henk B. Kal, A van der Does-van den Berg, Jaak M. Vossen	20
14	Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia 2001 ·Leukemia ·(unknown), Tom Révész, Marc Bierings, (unknown), ER van Wering, K. Hählen, A van der Does-van den Berg	57
15	Two consecutive immunophenotypic switches in a child with immunogenotypically stable acute leukaemia 2001 ·British Journal of Haematology ·Marc Bierings, Tomasz Szczepański, Elisabeth R. van Wering, MJ Willemse, Anton W. Langerak, Tom Révész, Jacques J. M. van Dongen	15
16	Diffuse Calcinosis cutis in a Patient with Congenital Leukemia and Leukemia cutis 2000 ·Dermatology ·G.G. Lestringant, Isabelle Masouyé, (unknown), Christophe Girardet, Tom Révész, Philippe M. Frossard	9
17	Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia 2000 ·British Journal of Haematology ·Andrew A. Lackner, Oliver Basu, Marc Bierings, Lisa Lassay, UW Schaefer, Tom Révész, W. Havers, (unknown)	36
18	[Congenital amegakaryocytic thrombocytopenia: indication for allogeneic stem cell transplantation]. 2000 ·PubMed ·(unknown), (unknown), Marc Bierings, Tom Révész	1
19	Identification of six novel WASP gene mutations in patients suffering from Wiskott-Aldrich syndrome 2000 ·Human Mutation ·Rik A. Brooimans, (unknown), R. Y. J. Tamminga, Tom Révész, Nico Wulffraat, B.J.M. Zegers	12
20	Treatment of Childhood Acute Nonlymphocytic Leukemia: Cooperative Austrian-Hungarian Study AML-IGCI-84 1990 ·Hämatologie und Bluttransfusion ·F. M. Fink, Helmut Gadner, (unknown), G Kardos, Tom Révész, Ch. Urban, I Mutz, (unknown), D. Schüler	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact